Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

July 15, 2021

Pivonello et al • 2021 • Front. Endocrinol., 14 July 2021